Uses of Lifibrat 100 and 300


Lifibrat is a drug acting on the vascular system, often indicated in hypercholesterolemia with increased triglycerides. So what is the mechanism of action and what should be noted when using the drug?

1. What are the effects of Lifibrat?


Lifibrat has the main ingredient Fenofibrate - a derivative of fibric acid with lipid-lowering effects. The mechanism of action of Fenofibrate is to inhibit cholesterol biosynthesis in the liver, reduce atherogenic components and reduce blood triglycerides. Lifibrat lowers blood cholesterol by 20-25% and blood triglycerides by 40-50%. At the same time, Lifibrat helps to improve plasma cholesterol distribution by reducing the ratio of total cholesterol to HDL cholesterol, reducing the risk of atherosclerosis. In addition, the component Fenofibrate can reduce extravascular cholesterol, increase urinary excretion of uric acid during long-term treatment and antiplatelet aggregation. Lifibrat is absorbed from the gastrointestinal tract, is strongly bound to plasma albumin and reaches peak plasma concentrations 5 hours after oral administration. Finally, the drug is excreted in the urine.

2. Indications of the drug Lifibrat


Lifibrat is indicated for the treatment of the following pathologies:
Simple hypercholesterolemia type IIa. Combined type IIb and type III hyperlipidemia. Single type IV endogenous hypertriglyceridemia. Persistent hyperlipoproteinemia secondary to diabetes mellitus (cause treated but not relieved). Hyperlipidemia diseases have applied diet and exercise but did not decrease.

3. Contraindications of Lifibrat


Lifibrat should not be used in the following cases:
Patients who are allergic to Fenofibrate or any other ingredient of the drug. Patients with severe renal impairment should not use Lifibrat due to the risk of nephrotoxicity. Liver dysfunction, gallbladder disease or severe liver failure. Children under 10 years old. Pregnant and lactating women taking the drug pose a risk of toxicity to the fetus and baby. Patients with photoallergic reactions during treatment with other fibrates or non-steroidal anti-inflammatory drugs (ketoprofen). Patients should note a number of problems when using Lifibrat, including:
Check liver function before and during treatment because the drug has a high risk of causing liver toxicity. Discontinue if liver enzymes (SGOT, SGPT) increase 3 times normal values. After 3 to 6 months of treatment, if plasma lipid levels do not decrease, additional or alternative therapy should be considered. The drug acts on the musculoskeletal system, so monitor for muscle-related symptoms during administration. Patients with cholestatic cirrhosis or gallstones when taking Lifibrat may have biliary tract complications. Monitor and check blood count periodically throughout the course of drug use.

4. Lifibrat drug interactions


Co-administration of Lifibrat with anticoagulants will increase the risk of bleeding. Do not use Lifibrat together with toxic drugs on the liver such as MAO inhibitors, Perhexiline maleate, ... will increase toxicity to the liver. Other fibrates, HMG CoA reductase inhibitors (Pravastatin, Simvastatin and Fluvastatin) when used together with Lifibrat will increase drug effects. To avoid interactions, before being prescribed Lifibrat, the patient should inform the doctor about the drugs they are using, including functional foods. The doctor will base on that to prescribe the appropriate Lifibrat.

5. Dosage and usage


How to use:
Lifibrat is prepared in the form of oral tablets, taken with the main meal. Use of the drug must be combined with a reasonable diet and exercise. Dosage:
Adults: 3 tablets (100mg tablets)/day. Children over 10 years: Use a maximum dose of 5 mg/kg/day.

6. Side effects of the drug Lifibrat


Some unwanted effects that may occur when using Lifibrat include:
Allergic reactions due to drugs, urticaria, itchy skin. Digestive disorders . Temporarily increased transaminase enzymes, increased SGOT, SGPT. Muscle pain. In summary, Lifibrat is a drug for the treatment of intravascular and extravascular dyslipidemia. The drug causes many side effects on the body, especially on the hepatobiliary system. Therefore, it is necessary to have a close monitoring of the doctor during the course of taking the drug. Using Lifibrat always needs to be combined with a suitable diet and exercise. Note, Lifibrat is a drug prescribed by a specialist, patients absolutely must not use it on their own.


Bài viết này được viết cho người đọc tại Sài Gòn, Hà Nội, Hồ Chí Minh, Phú Quốc, Nha Trang, Hạ Long, Hải Phòng, Đà Nẵng.

12 lượt đọc

Dịch vụ từ Vinmec

Bài viết liên quan
  • Nhiễm độc giáp kèm tăng Lipid máu điều trị thế nào?
    Nhiễm độc giáp kèm tăng Lipid máu điều trị thế nào?

    Cháu bị nhiễm độc giáp, rối loạn chuyển hóa Lipoprotein và tình trạng tăng Lipid máu khác. Kết quả xét nghiệm của cháu: T3: 2,93; FT4 : 20,53; TSH :7,249. Vậy bác sĩ cho cháu hỏi nhiễm độc giáp kèm ...

    Đọc thêm
  • Lipidtab 10
    Công dụng thuốc Lipidtab 10

    Thuốc Lipidtab 10 là thuốc được sử dụng cùng chế độ ăn uống để giảm mỡ máu và giúp phòng ngừa biến cố tim mạch cho những người có nguy cơ cao.

    Đọc thêm
  • Agivasta
    Công dụng thuốc Agivasta

    Agivasta thuộc nhóm thuốc điều trị tăng lipid máu có thành phần chính là Pravastatin. Thuốc được bào chế dưới dạng viên nén, hộp 3 vỉ x 10 viên. Ngoài tác dụng hạ mỡ máu, Agivasta còn được sử dụng ...

    Đọc thêm
  • Công dụng thuốc Lipitra
    Công dụng thuốc Lipitra

    Thuốc Lipitra chứa thành phần chính là Atorvastatin. Hiện nay, trên thị trường biệt dược Lipitra có 3 hàm lượng chính là 10mg, 20mg và 40mg. Đây là thuốc được chỉ định cho những bệnh nhân bị tăng lipid máu. ...

    Đọc thêm
  • lapoce
    Công dụng thuốc Lapoce

    Thuốc Lapoce thuộc nhóm thuốc tim mạch được bào chế ở dạng viên nén bao phim. Thành phần chính của thuốc là Bezafibrate được chỉ định trong điều trị tăng lipoprotein máu nguyên phát.

    Đọc thêm